Peer review reports
From: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases
Original Submission | ||
---|---|---|
30 Aug 2018 | Submitted | Original manuscript |
22 Sep 2018 | Reviewed | Reviewer Report - Chi-Lu Chiang |
22 Sep 2018 | Reviewed | Reviewer Report - Sreenivasan Sasidharan |
21 Oct 2018 | Author responded | Author comments - Wan Ling Tan |
Resubmission - Version 2 | ||
21 Oct 2018 | Submitted | Manuscript version 2 |
11 Nov 2018 | Author responded | Author comments - Wan Ling Tan |
Resubmission - Version 3 | ||
11 Nov 2018 | Submitted | Manuscript version 3 |
19 Nov 2018 | Author responded | Author comments - Wan Ling Tan |
Resubmission - Version 4 | ||
19 Nov 2018 | Submitted | Manuscript version 4 |
Publishing | ||
20 Nov 2018 | Editorially accepted | |
3 Dec 2018 | Article published | 10.1186/s12885-018-5110-2 |